Navigation Links
Epizyme, Inc. to Present at Upcoming Conferences in September
Date:8/28/2013

CAMBRIDGE, Mass., Aug. 28, 2013 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in upcoming September conferences.

  • Citi 8th Annual Biotech Day at the Mandarin Oriental Hotel in Boston, Mass. on Wednesday, September 4th
  • JMP Securities Biotech Day at the Langham Hotel in Boston, Mass. on Friday, September 6th at 11:00 a.m. ET.
  • Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, N.Y. on Wednesday, September 11th at 8:00 a.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.
  • Stifel Nicolaus Healthcare Conference 2013 at the Four Seasons Hotel in Boston, Mass. on Thursday, September 12th at 2:05 p.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.
  • BioPharm America Conference at the Westin Boston Waterfront in Boston, Mass. on Tuesday, September 17th at 2:45 p.m. ET in a panel discussion titled "Partnering: Thinking beyond the deal."
  • Cancer Advance Boston at the Harvard Medical School in Boston, Mass. on Thursday, September 19th at 3:00 p.m. ET in a panel discussion titled "Redefining Cancer: Insights from Cancer Stem Cells, Epigenetics, Immunotherapy and More."
  • LES Annual Meeting at the Philadelphia Marriott Downtown in Philadelphia, Pa. on Monday, September 23rd at 12:15 p.m. ET to receive the 2013 LES Deal of Distinction Award in the Life Sciences Sector.
  • Discovery On Target 2013 at the Westin Boston Waterfront in Boston, Mass. on Tuesday, September 24th at 11:45 a.m. ET, presenting on targeting histone methyltransferases in cancer therapy.
  • BioCentury's NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center in New York, N.Y. on Friday, September 27th at 9:00 a.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.

About Epizyme, Inc.
Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment.

For more information, visit http://www.epizyme.com and connect with us on Twitter at @EpizymeRx.


'/>"/>
SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Epizyme, Inc. to Present at Wedbush Securities Life Sciences Management Access Conference in August
2. Epizyme, Inc. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on July 31, 2013
3. Epizyme, Inc. Announces Pricing of Initial Public Offering
4. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Genocea Biosciences Selected To Present Late-Breaking Oral Presentation At ICAAC 2013
6. BioLineRx to Present at 15th International Celiac Disease Symposium
7. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
8. Affordable IVF Presents A Free Information Evening
9. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
10. Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast
11. Zimmer Holdings to Present at UBS Best of Americas Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Anaplastic Oligoastrocytoma - Pipeline Review, H2 ... Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma ... of the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. ... when two types of cells in the brain, ... to form a mass. These brain cells are ...
(Date:12/6/2016)... -- Human Vaccines Market: Scope and Methodology ... wise analysis of the human vaccines market. Stakeholders ... products, raw material suppliers, vaccine processing companies, and ... The report provides qualitative and quantitative analysis of ... market dynamics, trends, product overview, and country-level market ...
(Date:12/6/2016)... , Dec. 6, 2016 Eurofins ... accreditation from the College of American Pathologists (CAP) ... (CLIA) for its new laboratory in ... moved its North American headquarters. "Our ... sequencing -- which is still considered the ,Gold ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “Walking With ... of stories that will inspire the reader to be aware of God's direction in ... of published author, Sanford Smith, retired teacher and active church leader. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... NuevaCare, a ... Peninsula region, is proud to announce new city-specific pages as part of its ambitious ... the elderly, they often look, first, for local agencies serving their city. The new ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce ... drinking more water or limiting their exposure to the sun, according to a November ... group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves ...
(Date:12/6/2016)... ... 06, 2016 , ... Mount Sinai Health System today announced the creation of ... can confer and order 3D models for their cases. Virtual reality, simulation, and ... times. This resource will be the first of its kind catering to the ...
Breaking Medicine News(10 mins):